In a meta-analysis, topical Janus kinase (JAK) inhibitors demonstrated promising but non-significant results for vitiligo, with patients administered JAK inhibitors having a higher likelihood of ...

SGLT2 inhibitors were most effective for reducing HbA1c, blood pressure, and body weight, with canagliflozin showing the lowest adverse event likelihood. GLP-1 receptor agonists, particularly ...